Brussels · In-House Procurement Counsel Recruiting
Brussels pharma counsel pay is a grade-and-LTIP stack, not a published band: Anderlecht headquarters hires Legal Procurement Leads against that shape, and a general counsel who waits for a printed range will miss the seat.
Sartori & Partners is highly technical in In-House Procurement Counsel Recruiting work in Brussels, with 17 closed searches over three years. Across 250 structured interviews with Brussels partners and counsel, Sartori heard in-house buyers describe pharma counsel pay as a grade, bonus, and LTIP stack rather than a published band. Our mandate telemetry on those 17 files shows a 27 percent counter-offer rate when equity eligibility stays unsigned.
01 — The brief answer
In Brussels, the ~6,000 lawyers Sartori maps for this market include a thin in-house pharma-counsel layer whose compensation is a grade, bonus, and LTIP stack rather than a published cash band.
A general counsel asking what a Legal Procurement Lead costs at Anderlecht headquarters will not find a printed range. Employers here do not publish bands for this seat. Package shape decides offers more than a headline salary the buyer cannot post. Firms searching for pharma counsel recruiters Brussels usually call us once a chief legal officer has a live procurement-counsel brief and no band to advertise.
UCB reported €7,741 million revenue for 2025 from its Brussels headquarters and 10,117 employees worldwide as of December 2025; that commercial engine in Anderlecht—not a satellite EU-affairs desk—is why in-house legal headcount follows neurology and immunology contracting. We have worked Brussels biopharmaceutical in-house search for 8 years, for general counsel and heads of legal hiring procurement counsel. Over the last three years we closed 17 In-House Procurement Counsel Recruiting searches with a 94 percent completion rate and a median timeline of 8 to 16 weeks.
Sartori's Brussels mandate telemetry records a 27 percent counter-offer incidence on this line when LTIP eligibility is left unsigned.
Years in this market
8years
Searches closed · 3 yrs
17
Completion rate
94%
Median timeline
8to 16 weeks
Sartori & Partners trailing record · In-House Procurement Counsel Recruiting · Brussels
02 — The bench
Sartori's Brussels mandate telemetry covers 6 Anderlecht HQ pharma-counsel files inside 17 closed searches over 36 months.
Those files show the Legal Procurement Lead brief as commercial contracting for global procurement, not EU-affairs drafting. Day to day the in-house lawyer advises procurement on commercial risk, drafts and negotiates consulting, technology, data, and external-workforce contracts, maintains templates, trains non-legal stakeholders, and supports disputes. Adjacent feeder seats are in-house commercial counsel, vendor-contracting lawyers, and life-sciences firm commercial specialists; a chief legal officer filling a team-lead variant also looks for lawyers who have already supported a chief procurement officer. A general counsel at a Brussels-headquartered biopharmaceutical company told us the hire fails if the candidate has only policy files and no vendor paper.
In 3 of those 6 files Sartori's first shortlist over-weighted EU-affairs counsel; we misjudge the procurement hybrid until the head of legal sends the contract log. Our Brussels offer telemetry records a median offer-to-acceptance of 13 working days on this line. HQ briefs on this line run 10 to 16 weeks in our files; EU-office legislation briefs run 8 to 12 weeks.
03 — Selected engagements
Anonymised mandates from our Brussels book — profile, complication and outcome. Select an engagement to open its file.
04 — The local market
Sartori's 2025–2026 survey wave covered 31 Brussels heads of legal in life sciences.
22 of that 31-person segment told Sartori they would add procurement or commercial counsel before a second EU-affairs lawyer.
UCB S.A. keeps global headquarters in Anderlecht and is the innovative-medicines group whose product legal work is run from a Brussels campus. UCB runs product legal work from Anderlecht headquarters. Pfizer SA sits in Ixelles with a clinical research unit in Anderlecht; GSK, Sanofi, AstraZeneca, Novartis, and Johnson & Johnson keep EU offices in the Brussels pentagon. Those EU-office sites are EU-affairs and corporate offices. Legal headcount follows headquarters commercial paper at UCB, and policy, IP, and legislation-implementation paper at the others.
pharma.be reported 44,738 direct biopharmaceutical jobs in Belgium in 2024, down 0.5 percent, and on 2 April 2026 published a 2025 break: exports -6.8 percent to €73.1 billion and patent filings -15.3 percent. Council and Parliament reached political agreement on 11 December 2025 on the first major revision of EU medicines law since 2004—eight years of data protection plus one year of market protection. EFPIA's Legal Affairs team at the Neo Building and Medicines for Europe near the European Parliament staff that implementation calendar. A head of legal at a European public-affairs office of a global innovative-medicines group said the 2025 package still does not replace an HQ procurement counsel.
Hiring in Brussels?
The market intelligence on this page is the same coverage we use to run retained in-house procurement counsel recruiting mandates in Brussels.
05 — Mandates we run
Of 17 closed In-House Procurement Counsel searches over 36 months, Sartori grouped 6 as Anderlecht HQ procurement-counsel mandates, 5 as EU-office legislation-implementation mandates, and 6 as commercial-vendor backfills at innovative-medicines groups. Six of those seventeen files were Anderlecht HQ procurement-counsel mandates.
HQ files run 10 to 16 weeks in our work: conflicts screening against association secondments, verification that the candidate has actually negotiated technology and contingent-workforce paper, and comp-structure friction when bonus eligibility is promised orally. Equity cliffs stall offers until the general counsel signs LTIP grade rules. Sartori's Brussels mandate telemetry shows 5 of 17 searches over 36 months stalled past week 14 when that signature was missing.
EU-office files run 8 to 12 weeks in our work against the 11 December 2025 pharma-package agreement. A chief legal officer at a national innovative-industry federation reported that association intern pipelines closed in 2026 without replacing a permanent legal-affairs manager, so company legal teams cannot borrow that capacity. Completion held at 94 percent because we closed 16 of 17 files; the withdrawn HQ brief followed a counter-offer on unsigned equity. Sartori records a 27 percent counter-offer incidence on this Brussels line. Our typical timeline remains 8 to 16 weeks. Median offer-to-acceptance on our Brussels telemetry is 13 working days.
06 — Compensation
Of 38 in-house pharma counsel in that Brussels cohort over 24 months, Sartori found 29 bonus-eligible from counsel grade, 8 with LTIP reserved for VP Legal or the layer below the chief legal officer, and 34 who named meal vouchers and hospitalization as table-stakes rather than differentiators.
Employers here do not publish bands for this seat. Grade and bonus eligibility plus LTIP access are the stack a general counsel actually negotiates. Sartori telemetry on 12 accepted offers over 24 months recorded a modal contractual notice of three months. Annual bonus attaches at counsel grade; equity does not. Hybrid office rules and group insurance appear on every in-house term sheet we saw in that 38-person segment; they do not close a gap when LTIP is withheld.
The 8-of-38 equity share is why Sartori's 27 percent counter-offer incidence concentrates on unsigned LTIP, not on meal vouchers. We cannot see a published Brussels pharma-counsel cash band, and we do not import one from another city or seat. UCB's 2025 facts pack states 10,117 employees and €7,741 million 2025 revenue; that scale funds HQ grades, not a posted range. Median offer-to-acceptance on our telemetry remains 13 working days once the head of legal signs the stack.
07 — Methodology
Sartori & Partners has worked the Brussels in-house market for 8 years. From the ~6,000 lawyers we map in Brussels, we draw mandate telemetry on 17 closed In-House Procurement Counsel searches, offer clocks, and quarterly survey waves running since 2019. That interview cohort supplies the in-house pharma-counsel cuts.
Public inputs are employer and official: UCB's 26 February 2026 FY 2025 release (€7,741 million revenue), the FY 2025 facts pack (10,117 employees as of December 2025), pharma.be's 2024 sector tables (44,738 direct jobs) and 2 April 2026 2025-trend note (€73.1 billion exports), and the Council's 11 December 2025 pharma-package agreement. We do not use recruiter surveys or imported city bands.
We cannot see a published Brussels pharma-counsel cash band. Internal files carry clocks the public record does not: 13 working days median offer-to-acceptance, 27 percent counter-offers, 8 to 16 week search clocks, 94 percent completion on 16 of 17 files. A general counsel or head of HR briefing an Anderlecht procurement-counsel search gets that instrumentation, not a scraped salary chart.
Hiring in Brussels?
Whether you are building a team or weighing a move, we listen first. No obligation.
08 — Sources
09 — Questions
Nobody audits pharma counsel recruiters in Brussels, so a shortlist is better built from coverage, method and completed mandates than from any ranking. Sartori & Partners maps roughly 6,000 lawyers in Brussels and has worked this market for 8 years. Over the trailing three years we closed 17 in-house procurement counsel recruiting searches here at a 94% completion rate, with a median timeline of 8 to 16 weeks. Across 250 structured interviews with Brussels partners and counsel, Sartori heard in-house buyers describe pharma counsel pay as a grade, bonus, and LTIP stack rather than a published band. In Sartori's 2025–2026 survey wave, 22 of 31 Brussels heads of legal in life sciences told Sartori they would add procurement or commercial counsel before a second EU-affairs lawyer. Cohort definitions, sample windows and method are published in our research programme, and every figure above is drawn from it.
Employers here do not publish bands for this seat; 38 in-house pharma counsel in our cohort said the same. Grade, bonus eligibility, LTIP, notice, and benefits are the stack a general counsel negotiates. Sartori does not import a cash band from another city or seat.
Our typical clocks run 8 to 16 weeks on this line. HQ Legal Procurement Lead files sit at 10 to 16 weeks; EU-office legislation files sit at 8 to 12 weeks. Over three years we closed 17 searches at a 94 percent completion rate.
Sartori records a 27 percent counter-offer incidence on this Brussels line. Incidence concentrates when LTIP eligibility is unsigned, matching the 8-of-38 equity share in that cohort. Median offer-to-acceptance is 13 working days once the head of legal signs the stack.
Our files show three feeder seats: in-house commercial counsel, vendor-contracting lawyers, and life-sciences commercial specialists. EU-affairs counsel fail the vendor-paper test on HQ procurement briefs. A general counsel at a Brussels-headquartered biopharmaceutical company told us the hire fails without that paper.
Median offer-to-acceptance is 13 working days on our Brussels telemetry. Notice is typically three months on the 12 accepted offers we clocked over 24 months. Counter-offers still hit 27 percent if equity remains unsigned through that window.
Related
In-house & general counsel · All services · Locations · Practice areas
